Growth Metrics

Eledon Pharmaceuticals (ELDN) Accounts Payables (2016 - 2017)

Historic Accounts Payables for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to $189000.0.

  • Eledon Pharmaceuticals' Accounts Payables fell 7866.82% to $189000.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $189000.0, marking a year-over-year decrease of 7866.82%. This contributed to the annual value of $338000.0 for FY2016, which is 7201.99% down from last year.
  • According to the latest figures from Q3 2017, Eledon Pharmaceuticals' Accounts Payables is $189000.0, which was down 7866.82% from $374000.0 recorded in Q2 2017.
  • Over the past 5 years, Eledon Pharmaceuticals' Accounts Payables peaked at $3.4 million during Q1 2015, and registered a low of $5000.0 during Q4 2013.
  • Its 5-year average for Accounts Payables is $1.2 million, with a median of $1.0 million in 2015.
  • Per our database at Business Quant, Eledon Pharmaceuticals' Accounts Payables soared by 1520000.0% in 2014 and then tumbled by 8536.59% in 2017.
  • Over the past 5 years, Eledon Pharmaceuticals' Accounts Payables (Quarter) stood at $5000.0 in 2013, then surged by 15200.0% to $765000.0 in 2014, then soared by 57.91% to $1.2 million in 2015, then tumbled by 72.02% to $338000.0 in 2016, then crashed by 44.08% to $189000.0 in 2017.
  • Its Accounts Payables stands at $189000.0 for Q3 2017, versus $374000.0 for Q2 2017 and $276000.0 for Q1 2017.